首页 | 本学科首页   官方微博 | 高级检索  
检索        

弥漫性大B细胞淋巴瘤bcl-2、bcl-6、CD_(10)、MUM1蛋白表达与亚分类
引用本文:陈愉,赵彤,蔡庆发,吴炳绪,陈美燕,林雨冬.弥漫性大B细胞淋巴瘤bcl-2、bcl-6、CD_(10)、MUM1蛋白表达与亚分类[J].中国现代医学杂志,2008,18(13).
作者姓名:陈愉  赵彤  蔡庆发  吴炳绪  陈美燕  林雨冬
作者单位:1. 福建省福州总医院九五临床部,病理科,福建,莆田,351100
2. 南方医科大学附属南方医院病理科,广东,广州,510515
3. 莆田学院附属医院病理科,福建,莆田,351100
4. 福建省福州总医院九五临床部肿瘤科,福建,莆田,351100
摘    要:目的探讨bcl-2、bcl-6、CD10、MUM1在弥漫性大B细胞淋巴瘤(diffuselarge B-cell lymphoma,DLBCL)中的表达及与亚分类的关系。方法应用免疫组织化学S-P法,检测60例弥漫性大B细胞淋巴瘤标本中bcl-2、bcl-6、CD10、MUM1蛋白的表达水平。结果bcl-2、bcl-6、CD10、MUMl在60例弥漫性大B细胞淋巴瘤中的表达率分别为55.0%(33/60)、48.3%(29/60)、46.7%(28/60)、58、3%(35/60),其中GCB占55.0%(33/60),non-GCB占45.O%(27/60)。GCB、non-GCB中bcl-2的表达差异具有显著性。在non-GCB中,bcl-6与bcl-6-的病例bcl-2表达的差异具有显著性。结论该组病例GCB所占的比率超过non-GCB,bcl-2在DLBCL亚分类中可能具有一定的作用。

关 键 词:bcl-2  bcl-6  CD10  MUM1  弥漫性大B细胞淋巴瘤  免疫组织化学  弥漫性  细胞淋巴瘤  蛋白表达  亚分类  lymphoma  large  diffuse  subgroups  significance  作用  表达差异  病例  表达率  结果  表达水平  标本  检测  免疫组织化学  应用  方法

Bcl-2, bcl-6, CD_(10), MUM1 protein and their significance in subgroups of diffuse large B-cell lymphoma
CHEN Yu,ZHAO Tong,CAI Qing-fa,WU Bing-xu,CHEN Mei-yan,LIN Yu-dong.Bcl-2, bcl-6, CD_(10), MUM1 protein and their significance in subgroups of diffuse large B-cell lymphoma[J].China Journal of Modern Medicine,2008,18(13).
Authors:CHEN Yu  ZHAO Tong  CAI Qing-fa  WU Bing-xu  CHEN Mei-yan  LIN Yu-dong
Institution:1. Department of Pathology;the 95th Military Hospital;Putian;Fujian 351100;P.R.China;2. Department of Pathology;the Affiliated Nanfang Hospital;South Medical University;Guangzhou;Guangdong 510515;3. Department of Pathology;the Affiliated Hospital;Putian College;4. Department of Tumor;P.R.China
Abstract:Objective] To investigate the expression of bcl-2, bcl-6, CD10, MUM1 protein and their significance in subgroups of diffuse large B-cell lymphoma. Methods] Immunohistochemistry technique (SP method) was used to assess the expression levels of bcl-2, bcl-6,CD10, MUM1 protein in 60 cases of diffuse large B-cell lymphoma. Results] The expression rates of bcl-2, bcl-6, CD10, MUM1 protein in 60 cases of diffuse large B-cell lymphoma was 55.0%, 48.3%, 46.7%, 58.3% respectively. Of the 60 cases, 55.0% (33/60) w...
Keywords:bcl-2  bcl-6  CD10  MUM1  diffuse large B-cell lymphoma  immunohistochemistry  subgroups  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号